+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Viral Vectors & Plasmid DNA Global Market Report 2020-30: COVID-19 Implications and Growth

  • ID: 5125733
  • Report
  • July 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 4D Molecular Therapeutics
  • Biovian
  • Lonza
  • Novasep
  • Plasmid Factory
  • Sanofi
  • MORE
Viral Vectors & Plasmid DNA Global Market Report 2020-30: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global viral vectors & plasmid dna market.

This report focuses on viral vectors & plasmid dna market which is experiencing strong growth. The report gives a guide to the viral vectors & plasmid dna market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the viral vectors & plasmid dna? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Viral Vectors & Plasmid DNA market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider viral vectors & plasmid dna market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The viral vectors & plasmid dna market section of the report gives context. It compares the viral vectors & plasmid dna market with other segments of the viral vectors & plasmid dna market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, viral vectors & plasmid dna indicators comparison.
Scope

Markets Covered:
1) By Product: Plasmid DNA; Viral vectors
2) By Applications: Gene And Cancer Therapies; Viral Infections; Immunotherapy; Formulation Development; Others

Companies Mentioned: FUJIFILM Diosynth Biotechnologies; FinVector Vision Therapies; Lonza; Cobra Biologics and Pharmaceutical Services; Brammer Bio

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 4D Molecular Therapeutics
  • Biovian
  • Lonza
  • Novasep
  • Plasmid Factory
  • Sanofi
  • MORE
1. Executive Summary

2. Viral Vectors & Plasmid DNA Market Characteristics

3. Viral Vectors & Plasmid DNA Market Size and Growth
3.1. Global Viral Vectors & Plasmid DNA Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers of the Market
3.1.2. Restraints on the Market
3.2. Global Viral Vectors & Plasmid DNA Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers of the Market
3.2.2. Restraints on the Market

4. Viral Vectors & Plasmid DNA Market Segmentation
4.1. Global Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Plasmid DNA
  • Viral vectors
4.2. Global Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Gene and Cancer Therapies
  • Viral Infections
  • Immunotherapy
  • Formulation Development
  • Others
5. Viral Vectors & Plasmid DNA Market Regional and Country Analysis
5.1. Global Viral Vectors & Plasmid DNA Market, Split by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Viral Vectors & Plasmid DNA Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Viral Vectors & Plasmid DNA Market
6.1. Asia-Pacific Viral Vectors & Plasmid DNA Market Overview
6.2. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Viral Vectors & Plasmid DNA Market
7.1. China Viral Vectors & Plasmid DNA Market Overview
7.2. China Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7.3. China Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

8. India Viral Vectors & Plasmid DNA Market
8.1. India Viral Vectors & Plasmid DNA Market Overview
8.2. India Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Viral Vectors & Plasmid DNA Market
9.1. Japan Viral Vectors & Plasmid DNA Market Overview
9.2. Japan Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Viral Vectors & Plasmid DNA Market
10.1. Australia Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Viral Vectors & Plasmid DNA Market
11.1. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Viral Vectors & Plasmid DNA Market
12.1. South Korea Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Viral Vectors & Plasmid DNA Market
13.1. Western Europe Viral Vectors & Plasmid DNA Market Overview
13.2. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Viral Vectors & Plasmid DNA Market
14.1. UK Viral Vectors & Plasmid DNA Market Overview
14.2. UK Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Viral Vectors & Plasmid DNA Market
15.1. Germany Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Viral Vectors & Plasmid DNA Market
16.1. France Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.2. France Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Viral Vectors & Plasmid DNA Market
17.1. Eastern Europe Viral Vectors & Plasmid DNA Market Overview
17.2. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Viral Vectors & Plasmid DNA Market
18.1. Russia Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Viral Vectors & Plasmid DNA Market
19.1. North America Viral Vectors & Plasmid DNA Market Overview
19.2. North America Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Viral Vectors & Plasmid DNA Market
20.1. USA Viral Vectors & Plasmid DNA Market Overview
20.2. USA Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Viral Vectors & Plasmid DNA Market
21.1. South America Viral Vectors & Plasmid DNA Market Overview
21.2. South America Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Viral Vectors & Plasmid DNA Market
22.1. Brazil Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Viral Vectors & Plasmid DNA Market
23.1. Middle East Viral Vectors & Plasmid DNA Market Overview
23.2. Middle East Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Viral Vectors & Plasmid DNA Market
24.1. Africa Viral Vectors & Plasmid DNA Market Overview
24.2. Africa Viral Vectors & Plasmid DNA Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Viral Vectors & Plasmid DNA Market, Segmentation by Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Viral Vectors & Plasmid DNA Market Competitive Landscape and Company Profiles
25.1. Viral Vectors & Plasmid DNA Market Competitive Landscape
25.2. Viral Vectors & Plasmid DNA Market Company Profiles
25.2.1. FUJIFILM Diosynth Biotechnologies
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. FinVector Vision Therapies
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Lonza
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Cobra Biologics and Pharmaceutical Services
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Brammer Bio
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers and Acquisitions in the Viral Vectors & Plasmid DNA Market

27. Viral Vectors & Plasmid DNA Market Trends and Strategies

28. Viral Vectors & Plasmid DNA Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • 4D Molecular Therapeutics
  • Biovian
  • Lonza
  • Novasep
  • Plasmid Factory
  • Sanofi
  • MORE
Major players in the viral vectors & plasmid DNA market are FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio, Каnеkа Соrроrаtіоn, Cell and Gene Therapy Catapult, VGXI, and MassBiologics.

The global viral vectors & plasmid DNA market is expected to grow from $0.46 billion in 2019 to $0.60 billion in 2020 at a compound annual growth rate (CAGR) of 31.3%. The growth is mainly due to the outbreak of COVID 19 and requires targeted delivery of the drug to treat affected patients. The number of cases has been increasing resulting in a surge in demand for viral vectors & plasmid DNA. The market is expected to reach $1.05 billion in 2023 at a CAGR of 20.4%.

The viral vectors & plasmid DNA market consists of sales of viral vectors & plasmid DNA and related services. The viral vectors & plasmid DNA are used for the delivery of cellular therapies, like gene therapy and immunotherapy, and also for treating some viral infections. The viral vectors & plasmid DNA are used for formulation development in research and development labs. The viral vectors are genetically engineered viruses carrying viral RNA or DNA that is noninfectious but still contain viral promoters and transgene. The plasmid DNA is a double-stranded extrachromosomal and circular DNA sequence that is capable of replication using the host cell's replication system.

North America was the largest region in the viral vectors and plasmid DNA market in 2019. Asia Pacific is expected to be the fastest-growing region in the forecast period.

In January 2020, Cognate Bioservices Inc, a US-based company skilled in cell and cell-mediated gene therapy products, acquired Cobra Biologics, specialized in providing manufacturing services for plasmid DNA and viral vector, for an undisclosed amount. The acquisition is expected to create a platform for the life cycle management of cell and gene therapy products. Cobra biologics is well established in the development and manufacture of a variety of viral vectors and DNA. The combined Cognate and Cobra expertise is expected to push both the businesses to a better position to respond to current and future market demand.

The viral vectors & plasmid DNA market covered in this report is segmented by product into plasmid DNA; viral vectors and by applications into gene and cancer therapies; viral infections; immunotherapy; formulation development; others.

The unaffordable cost of gene therapies is a major challenge in the viral vectors & plasmid DNA market. The prices of gene therapies range between $0.2 million to $2.1 million. For instance, Gilead company's Yescarta is a gene therapy that costs around $0.3 million and Bluebird Bio's Letiglobin is another gene therapy costing around $2.1 million. The high price is due to various factors like government regulations, production costs, and so on. Therefore, the unaffordable cost of gene therapies is limiting the viral vector & plasmid DNA market growth.

The rise in the global incidence of cancer is driving the viral vector & plasmid DNA market. According to Cancer Research UK, in 2018, around 17 million new cases of cancer were recorded with deaths of around 9.6 million, and the estimated cancer incidence rate is 62% between 2018-2040 worldwide. The rise in the global incidence of cancer has boosted the demand for the viral vectors and plasmid DNA market.
Note: Product cover images may vary from those shown
4 of 5
  • FUJIFILM Diosynth Biotechnologies
  • FinVector Vision Therapies
  • Lonza
  • Cobra Biologics and Pharmaceutical Services
  • Brammer Bio
  • Каnеkа Соrроrаtіоn
  • Cell and Gene Therapy Catapult
  • VGXI
  • MassBiologics
  • Sanofi
  • Spark Therapeutics
  • UniQure
  • Thermo Fisher Scientific
  • VIROVEK
  • SIRION Biotech GmbH
  • ALDEVRON
  • Oxford BioMedica
  • Plasmid Factory
  • Biovian
  • BioReliance
  • 4D Molecular Therapeutics
  • Renova Therapeutics
  • Shenzhen SiBiono GeneTech Co.
  • Vigene Biosciences Inc.
  • Novasep
  • Genzyme Corporation
  • Oxford Gene Technology
  • Richter-Helm
  • Муlаn NV
  • MolMed
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll